HEADER TRANSFERASE 24-MAY-22 7ZY8 TITLE CRYSTAL STRUCTURE OF COMPOUND 2 BOUND TO CK2ALPHA COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 2-329 AND N-TERMINAL EXTENSION COMPND 5 GSMDIEFDDDADDDGSGSGSGSGS; COMPND 6 SYNONYM: CK II ALPHA; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1, CK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FRAGMENT BASED DRUG DISCOVERY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.BREAR,C.FUSCO,E.ATKINSON,M.ROSSMANN,N.FRANCIS,J.IEGRE,M.HYVONEN, AUTHOR 2 D.SPRING REVDAT 3 07-FEB-24 7ZY8 1 REMARK REVDAT 2 29-MAR-23 7ZY8 1 JRNL REVDAT 1 12-OCT-22 7ZY8 0 JRNL AUTH P.BREAR,C.DE FUSCO,E.L.ATKINSON,J.IEGRE,N.J.FRANCIS-NEWTON, JRNL AUTH 2 A.R.VENKITARAMAN,M.HYVONEN,D.R.SPRING JRNL TITL A FRAGMENT-BASED APPROACH LEADING TO THE DISCOVERY OF JRNL TITL 2 INHIBITORS OF CK2 ALPHA WITH A NOVEL MECHANISM OF ACTION. JRNL REF RSC MED CHEM V. 13 1420 2022 JRNL REFN ESSN 2632-8682 JRNL PMID 36426237 JRNL DOI 10.1039/D2MD00161F REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 166.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 63564 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 3227 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.90 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.74 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4651 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2505 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4403 REMARK 3 BIN R VALUE (WORKING SET) : 0.2478 REMARK 3 BIN FREE R VALUE : 0.3002 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.33 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 248 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5495 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 311 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.90970 REMARK 3 B22 (A**2) : -7.35180 REMARK 3 B33 (A**2) : 2.44210 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.230 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.141 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.123 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.139 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.123 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5742 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7773 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2035 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 144 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 845 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5742 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 688 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6566 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.93 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.85 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.13 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZY8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1292123291. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-APR-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.968610 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.17 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63759 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.849 REMARK 200 RESOLUTION RANGE LOW (A) : 166.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : 0.10900 REMARK 200 FOR THE DATA SET : 13.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.80800 REMARK 200 R SYM FOR SHELL (I) : 0.80800 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5MOH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 112.5MM MES PH 6.5, 35% GLYCEROL REMARK 280 ETHOXYLATE, 180 MM AMMONIUM ACETATE, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 166.93300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 166.93300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 32.47600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 33.98300 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 32.47600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 33.98300 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 166.93300 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 32.47600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 33.98300 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 166.93300 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 32.47600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 33.98300 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -22 REMARK 465 SER A -21 REMARK 465 MET A -20 REMARK 465 ASP A -19 REMARK 465 ILE A -18 REMARK 465 GLU A -17 REMARK 465 PHE A -16 REMARK 465 ASP A -15 REMARK 465 ASP A -14 REMARK 465 ASP A -13 REMARK 465 ALA A -12 REMARK 465 ASP A -11 REMARK 465 ASP A -10 REMARK 465 ASP A -9 REMARK 465 GLY A -8 REMARK 465 SER A -7 REMARK 465 GLY A -6 REMARK 465 SER A -5 REMARK 465 GLY A -4 REMARK 465 SER A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 GLY A 0 REMARK 465 SER A 1 REMARK 465 SER A 2 REMARK 465 VAL A 328 REMARK 465 LYS A 329 REMARK 465 GLY B -22 REMARK 465 SER B -21 REMARK 465 MET B -20 REMARK 465 ASP B -19 REMARK 465 ILE B -18 REMARK 465 GLU B -17 REMARK 465 PHE B -16 REMARK 465 ASP B -15 REMARK 465 ASP B -14 REMARK 465 ASP B -13 REMARK 465 ALA B -12 REMARK 465 ASP B -11 REMARK 465 ASP B -10 REMARK 465 ASP B -9 REMARK 465 GLY B -8 REMARK 465 SER B -7 REMARK 465 GLY B -6 REMARK 465 SER B -5 REMARK 465 GLY B -4 REMARK 465 SER B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 GLY B 0 REMARK 465 SER B 1 REMARK 465 SER B 2 REMARK 465 LYS B 329 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O4 PO4 B 404 O HOH B 501 1.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NE ARG B 268 NE ARG B 268 4597 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 105 -73.31 -87.38 REMARK 500 ASP A 156 43.32 -147.30 REMARK 500 ASP A 175 81.65 53.26 REMARK 500 ALA A 193 160.66 68.02 REMARK 500 ASP A 210 -158.36 -145.03 REMARK 500 VAL B 105 -73.47 -87.20 REMARK 500 ASP B 156 41.73 -145.11 REMARK 500 ASP B 175 81.49 51.16 REMARK 500 ALA B 193 158.80 61.95 REMARK 500 ALA B 193 162.18 61.95 REMARK 500 ASP B 210 -158.00 -147.82 REMARK 500 GLU B 282 -9.64 -58.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ARG A 19 -11.27 REMARK 500 ARG A 19 -11.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 600 DISTANCE = 5.83 ANGSTROMS DBREF 7ZY8 A 2 329 UNP P68400 CSK21_HUMAN 2 329 DBREF 7ZY8 B 2 329 UNP P68400 CSK21_HUMAN 2 329 SEQADV 7ZY8 GLY A -22 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER A -21 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 MET A -20 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP A -19 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ILE A -18 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLU A -17 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 PHE A -16 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP A -15 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP A -14 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP A -13 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ALA A -12 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP A -11 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP A -10 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP A -9 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLY A -8 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER A -7 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLY A -6 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER A -5 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLY A -4 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER A -3 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLY A -2 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER A -1 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLY A 0 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER A 1 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER A 21 UNP P68400 ARG 21 ENGINEERED MUTATION SEQADV 7ZY8 GLY B -22 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER B -21 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 MET B -20 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP B -19 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ILE B -18 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLU B -17 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 PHE B -16 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP B -15 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP B -14 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP B -13 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ALA B -12 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP B -11 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP B -10 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 ASP B -9 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLY B -8 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER B -7 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLY B -6 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER B -5 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLY B -4 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER B -3 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLY B -2 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER B -1 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 GLY B 0 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER B 1 UNP P68400 EXPRESSION TAG SEQADV 7ZY8 SER B 21 UNP P68400 ARG 21 ENGINEERED MUTATION SEQRES 1 A 352 GLY SER MET ASP ILE GLU PHE ASP ASP ASP ALA ASP ASP SEQRES 2 A 352 ASP GLY SER GLY SER GLY SER GLY SER GLY SER SER GLY SEQRES 3 A 352 PRO VAL PRO SER ARG ALA ARG VAL TYR THR ASP VAL ASN SEQRES 4 A 352 THR HIS ARG PRO SER GLU TYR TRP ASP TYR GLU SER HIS SEQRES 5 A 352 VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR GLN LEU VAL SEQRES 6 A 352 ARG LYS LEU GLY ARG GLY LYS TYR SER GLU VAL PHE GLU SEQRES 7 A 352 ALA ILE ASN ILE THR ASN ASN GLU LYS VAL VAL VAL LYS SEQRES 8 A 352 ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE LYS ARG GLU SEQRES 9 A 352 ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY PRO ASN ILE SEQRES 10 A 352 ILE THR LEU ALA ASP ILE VAL LYS ASP PRO VAL SER ARG SEQRES 11 A 352 THR PRO ALA LEU VAL PHE GLU HIS VAL ASN ASN THR ASP SEQRES 12 A 352 PHE LYS GLN LEU TYR GLN THR LEU THR ASP TYR ASP ILE SEQRES 13 A 352 ARG PHE TYR MET TYR GLU ILE LEU LYS ALA LEU ASP TYR SEQRES 14 A 352 CYS HIS SER MET GLY ILE MET HIS ARG ASP VAL LYS PRO SEQRES 15 A 352 HIS ASN VAL MET ILE ASP HIS GLU HIS ARG LYS LEU ARG SEQRES 16 A 352 LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR HIS PRO GLY SEQRES 17 A 352 GLN GLU TYR ASN VAL ARG VAL ALA SER ARG TYR PHE LYS SEQRES 18 A 352 GLY PRO GLU LEU LEU VAL ASP TYR GLN MET TYR ASP TYR SEQRES 19 A 352 SER LEU ASP MET TRP SER LEU GLY CYS MET LEU ALA SER SEQRES 20 A 352 MET ILE PHE ARG LYS GLU PRO PHE PHE HIS GLY HIS ASP SEQRES 21 A 352 ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS VAL LEU GLY SEQRES 22 A 352 THR GLU ASP LEU TYR ASP TYR ILE ASP LYS TYR ASN ILE SEQRES 23 A 352 GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU GLY ARG HIS SEQRES 24 A 352 SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SER GLU ASN SEQRES 25 A 352 GLN HIS LEU VAL SER PRO GLU ALA LEU ASP PHE LEU ASP SEQRES 26 A 352 LYS LEU LEU ARG TYR ASP HIS GLN SER ARG LEU THR ALA SEQRES 27 A 352 ARG GLU ALA MET GLU HIS PRO TYR PHE TYR THR VAL VAL SEQRES 28 A 352 LYS SEQRES 1 B 352 GLY SER MET ASP ILE GLU PHE ASP ASP ASP ALA ASP ASP SEQRES 2 B 352 ASP GLY SER GLY SER GLY SER GLY SER GLY SER SER GLY SEQRES 3 B 352 PRO VAL PRO SER ARG ALA ARG VAL TYR THR ASP VAL ASN SEQRES 4 B 352 THR HIS ARG PRO SER GLU TYR TRP ASP TYR GLU SER HIS SEQRES 5 B 352 VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR GLN LEU VAL SEQRES 6 B 352 ARG LYS LEU GLY ARG GLY LYS TYR SER GLU VAL PHE GLU SEQRES 7 B 352 ALA ILE ASN ILE THR ASN ASN GLU LYS VAL VAL VAL LYS SEQRES 8 B 352 ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE LYS ARG GLU SEQRES 9 B 352 ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY PRO ASN ILE SEQRES 10 B 352 ILE THR LEU ALA ASP ILE VAL LYS ASP PRO VAL SER ARG SEQRES 11 B 352 THR PRO ALA LEU VAL PHE GLU HIS VAL ASN ASN THR ASP SEQRES 12 B 352 PHE LYS GLN LEU TYR GLN THR LEU THR ASP TYR ASP ILE SEQRES 13 B 352 ARG PHE TYR MET TYR GLU ILE LEU LYS ALA LEU ASP TYR SEQRES 14 B 352 CYS HIS SER MET GLY ILE MET HIS ARG ASP VAL LYS PRO SEQRES 15 B 352 HIS ASN VAL MET ILE ASP HIS GLU HIS ARG LYS LEU ARG SEQRES 16 B 352 LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR HIS PRO GLY SEQRES 17 B 352 GLN GLU TYR ASN VAL ARG VAL ALA SER ARG TYR PHE LYS SEQRES 18 B 352 GLY PRO GLU LEU LEU VAL ASP TYR GLN MET TYR ASP TYR SEQRES 19 B 352 SER LEU ASP MET TRP SER LEU GLY CYS MET LEU ALA SER SEQRES 20 B 352 MET ILE PHE ARG LYS GLU PRO PHE PHE HIS GLY HIS ASP SEQRES 21 B 352 ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS VAL LEU GLY SEQRES 22 B 352 THR GLU ASP LEU TYR ASP TYR ILE ASP LYS TYR ASN ILE SEQRES 23 B 352 GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU GLY ARG HIS SEQRES 24 B 352 SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SER GLU ASN SEQRES 25 B 352 GLN HIS LEU VAL SER PRO GLU ALA LEU ASP PHE LEU ASP SEQRES 26 B 352 LYS LEU LEU ARG TYR ASP HIS GLN SER ARG LEU THR ALA SEQRES 27 B 352 ARG GLU ALA MET GLU HIS PRO TYR PHE TYR THR VAL VAL SEQRES 28 B 352 LYS HET PO4 A 401 5 HET ACT B 401 4 HET ACT B 402 4 HET PO4 B 403 5 HET PO4 B 404 5 HET KE0 B 405 12 HET KE0 B 406 12 HETNAM PO4 PHOSPHATE ION HETNAM ACT ACETATE ION HETNAM KE0 3-[3,5-BIS(CHLORANYL)PHENYL]PROPAN-1-AMINE FORMUL 3 PO4 3(O4 P 3-) FORMUL 4 ACT 2(C2 H3 O2 1-) FORMUL 8 KE0 2(C9 H11 CL2 N) FORMUL 10 HOH *311(H2 O) HELIX 1 AA1 PRO A 20 ASP A 25 1 6 HELIX 2 AA2 TYR A 26 HIS A 29 5 4 HELIX 3 AA3 LYS A 74 ARG A 89 1 16 HELIX 4 AA4 ASP A 120 LEU A 128 1 9 HELIX 5 AA5 THR A 129 MET A 150 1 22 HELIX 6 AA6 LYS A 158 HIS A 160 5 3 HELIX 7 AA7 SER A 194 LYS A 198 5 5 HELIX 8 AA8 GLY A 199 VAL A 204 1 6 HELIX 9 AA9 TYR A 211 ARG A 228 1 18 HELIX 10 AB1 ASP A 237 GLY A 250 1 14 HELIX 11 AB2 GLY A 250 ASN A 262 1 13 HELIX 12 AB3 ASP A 266 ASN A 270 5 5 HELIX 13 AB4 ARG A 280 VAL A 285 5 6 HELIX 14 AB5 SER A 294 LEU A 305 1 12 HELIX 15 AB6 ASP A 308 ARG A 312 5 5 HELIX 16 AB7 THR A 314 GLU A 320 1 7 HELIX 17 AB8 HIS A 321 TYR A 325 5 5 HELIX 18 AB9 PRO B 20 ASP B 25 1 6 HELIX 19 AC1 TYR B 26 HIS B 29 5 4 HELIX 20 AC2 LYS B 74 ARG B 89 1 16 HELIX 21 AC3 ASP B 120 GLN B 126 1 7 HELIX 22 AC4 THR B 129 MET B 150 1 22 HELIX 23 AC5 LYS B 158 HIS B 160 5 3 HELIX 24 AC6 SER B 194 LYS B 198 5 5 HELIX 25 AC7 GLY B 199 VAL B 204 1 6 HELIX 26 AC8 TYR B 211 ARG B 228 1 18 HELIX 27 AC9 ASP B 237 GLY B 250 1 14 HELIX 28 AD1 THR B 251 TYR B 261 1 11 HELIX 29 AD2 ASP B 266 ASN B 270 5 5 HELIX 30 AD3 ARG B 280 VAL B 285 5 6 HELIX 31 AD4 ASN B 289 VAL B 293 5 5 HELIX 32 AD5 SER B 294 LEU B 305 1 12 HELIX 33 AD6 ASP B 308 ARG B 312 5 5 HELIX 34 AD7 THR B 314 GLU B 320 1 7 HELIX 35 AD8 HIS B 321 TYR B 325 5 5 SHEET 1 AA1 6 GLY A 34 ASN A 35 0 SHEET 2 AA1 6 LEU A 97 LYS A 102 1 O ILE A 100 N GLY A 34 SHEET 3 AA1 6 PRO A 109 GLU A 114 -1 O VAL A 112 N ALA A 98 SHEET 4 AA1 6 LYS A 64 LEU A 70 -1 N VAL A 66 O PHE A 113 SHEET 5 AA1 6 SER A 51 ASN A 58 -1 N PHE A 54 O VAL A 67 SHEET 6 AA1 6 TYR A 39 ARG A 47 -1 N LEU A 45 O VAL A 53 SHEET 1 AA2 2 ILE A 152 MET A 153 0 SHEET 2 AA2 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 AA3 2 VAL A 162 ASP A 165 0 SHEET 2 AA3 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 SHEET 1 AA4 6 GLY B 34 ASN B 35 0 SHEET 2 AA4 6 LEU B 97 LYS B 102 1 O ILE B 100 N GLY B 34 SHEET 3 AA4 6 PRO B 109 GLU B 114 -1 O VAL B 112 N ALA B 98 SHEET 4 AA4 6 LYS B 64 LEU B 70 -1 N VAL B 66 O PHE B 113 SHEET 5 AA4 6 SER B 51 ASN B 58 -1 N PHE B 54 O VAL B 67 SHEET 6 AA4 6 TYR B 39 ARG B 47 -1 N LEU B 45 O VAL B 53 SHEET 1 AA5 2 ILE B 152 MET B 153 0 SHEET 2 AA5 2 GLU B 180 PHE B 181 -1 O GLU B 180 N MET B 153 SHEET 1 AA6 2 VAL B 162 ASP B 165 0 SHEET 2 AA6 2 LYS B 170 LEU B 173 -1 O LYS B 170 N ASP B 165 CISPEP 1 GLU A 230 PRO A 231 0 -7.26 CISPEP 2 GLU B 230 PRO B 231 0 -6.13 CRYST1 64.952 67.966 333.866 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015396 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014713 0.000000 0.00000 SCALE3 0.000000 0.000000 0.002995 0.00000